Bayes analysis provides evidence of pathogenicity for the BRCA1 c.135-1G>T (IVS3-1) and BRCA2 c.7977-1G>C (IVS17-1) variants displaying in vitro splicing results of equivocal clinical significance
about
Bayesian models for syndrome- and gene-specific probabilities of novel variant pathogenicity.Reduced canine BRCA2 expression levels in mammary gland tumorsReport of a novel OCA2 gene mutation and an investigation of OCA2 variants on melanoma risk in a familial melanoma pedigree.BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk.BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer.Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members.
P2860
Bayes analysis provides evidence of pathogenicity for the BRCA1 c.135-1G>T (IVS3-1) and BRCA2 c.7977-1G>C (IVS17-1) variants displaying in vitro splicing results of equivocal clinical significance
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Bayes analysis provides eviden ...... quivocal clinical significance
@ast
Bayes analysis provides eviden ...... quivocal clinical significance
@en
type
label
Bayes analysis provides eviden ...... quivocal clinical significance
@ast
Bayes analysis provides eviden ...... quivocal clinical significance
@en
prefLabel
Bayes analysis provides eviden ...... quivocal clinical significance
@ast
Bayes analysis provides eviden ...... quivocal clinical significance
@en
P2093
P2860
P50
P356
P1433
P1476
Bayes analysis provides eviden ...... quivocal clinical significance
@en
P2093
David E Goldgar
Leonard M Da Silva
Rosemary L Balleine
P2860
P304
P356
10.1002/HUMU.21181
P577
2010-02-01T00:00:00Z